| Judith Renee Murphree, | |
|
1790 W Government St, Brandon, MS 39042-2411 | |
| (601) 825-3473 | |
| Not Available |
| Full Name | Judith Renee Murphree |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1790 W Government St, Brandon, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245843283 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | E-08110 (Mississippi) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Judith Renee Murphree, 403 Apple Blossom Cv, Brandon, MS 39047-7694 Ph: (662) 255-0704 | Judith Renee Murphree, 1790 W Government St, Brandon, MS 39042-2411 Ph: (601) 825-3473 |
News Archive
TomoTherapy Incorporated announced today that the first patients are now being treated with the TomoDirect™ radiation therapy delivery mode at the University of Virginia Cancer Center. The addition of the TomoDirect modality to the TomoTherapy® platform gives clinicians an efficient new option that expands their ability to fight cancer.
Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today that the US Food and Drug Administration (FDA) has approved its New Drug Application for Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% as a treatment for acute herpetic keratitis (dendritic ulcers). The FDA granted orphan drug designation to Zirgan for this indication in April 2007.
Consumer-directed health plans offer low premiums but high deductibles on the premise that patients who are faced with deductibles of $1,000 or more for individual coverage (or twice that for family coverage) will shop around for the best price for the health care.
Democrats are "plotting a comeback" after losing the message war in August, and Sen. Max Baucus says health care reform is still likely this year.
Elderly patients undergoing PCI often receive bare-metal stents (BMS) instead of drug-eluting stents (DES) to shorten the duration of dual antiplatelet therapy (DAPT) and reduce bleeding risk. However, results from the SENIOR trial found that compared with BMS, shorter DAPT combined with the Synergy bioabsorbable polymer DES leads to less adverse events without increasing bleeding risk.
› Verified 1 days ago
Jonathan Gaston Box, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1070 Spillway Cir, Brandon, MS 39047 Phone: 601-829-0743 | |
Kimberly Ann Thornton, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1790 W Government St, Brandon, MS 39042 Phone: 601-825-3473 | |
Mr. Paul Roberson Lewis, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 202 Glen Trl, Brandon, MS 39047 Phone: 601-421-4597 Fax: 601-919-0017 | |
Dr. Douglas R Welch, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1645 W Government Cove, Suite E, Brandon, MS 39042 Phone: 601-720-5775 Fax: 601-825-2356 | |
James Davis Wilson, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 335 Crossgates Blvd, Brandon, MS 39042 Phone: 601-825-8660 | |
Mr. Johnny M Caldwell, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1790 W Gov St, Brandon, MS 39042 Phone: 601-825-3473 Fax: 601-825-5909 | |
Dr. Kayla Ledford, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1811 W Government St, Brandon, MS 39042 Phone: 601-613-2514 |